GroupKALSHI

Event GroupKALSHIScience and Technology

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Total Volume

$0.00

Events

Markets

Trade on Kalshi

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Vol

$0.00

Events

Markets

Kalshi

Platform StatsQuick Platform Comparison

Polymarket

markets · $0.00

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Price ChartMatched Markets Price Graph

5 markets tracked

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

No data available

Single-Platform Markets(5)

Market	Platform	Price
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)	Kalshi	86%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)	Kalshi	82%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)	Kalshi	72%
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)	Kalshi	48%
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)	Kalshi	31%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

86%

Top Probability

$0.00

Volume

Markets

Platforms

About This Event

COMP360 Psilocybin for Treatment-Resistant Depression If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Friday, July 10, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** When will the FDA approve Compass Pathways' COMP360 Psilocybin?
**Category:** Science and Technology | **Status:** active
**Resolution Date:** N/A (Unknown)
**Time Pressure:** Unknown

**Description:** COMP360 Psilocybin for Treatment-Resistant Depression

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

**Resolution Criteria (Sample):**
"If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs."

## 2. Market liquidity & Volume
* **Total Volume:** $0
* **Total Liquidity:** $0
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.00)

## 3. Market Data (Prices & Odds)
### 1. Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)
- **Kalshi** (End: Mar 8, 2027): Vol $0
  DATA: [Yes: 47.5% (0.0%)] | [No: 52.5% (0.0%)]

### 2. Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)
- **Kalshi** (End: Jan 8, 2027): Vol $0
  DATA: [Yes: 30.5% (0.0%)] | [No: 69.5% (0.0%)]

### 3. When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)
- **Kalshi** (End: Jan 8, 2028): Vol $0
  DATA: [Yes: 85.5% (0.0%)] | [No: 14.5% (0.0%)]

### 4. When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)
- **Kalshi** (End: Oct 8, 2027): Vol $0
  DATA: [Yes: 81.5% (0.0%)] | [No: 18.5% (0.0%)]

### 5. When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)
- **Kalshi** (End: Jul 8, 2027): Vol $0
  DATA: [Yes: 72.0% (0.0%)] | [No: 28.0% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

KALSHIScience and Technology

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Volume$0.00

Markets5

5 of 5

Sort:

KALSHI

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

KALSHI

KKalshi

Yes 85.5¢No 14.5¢

KALSHIHealth

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

KALSHI

KKalshi

Yes 81.5¢No 18.5¢

KALSHIHealth

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

KALSHI

KKalshi

Yes 72.0¢No 28.0¢

KALSHIHealth

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

KALSHI

KKalshi

Yes 47.5¢No 52.5¢

KALSHIHealth

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

KALSHI

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

KALSHI

KKalshi

Yes 30.5¢No 69.5¢

KALSHIHealth

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

No related news found

Discussion

0 Comments

Market Insights

Average Yes Price

63¢

Kalshi

Arbitrage Opps

Cross-Platform

Embed Widget

Add this market to your website

Volume

Platforms

HTML

<iframe src="https://predictpedia.com/embed/laxP-U" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="When will the FDA approve Compass Pathways' COMP360 Psilocybin?"></iframe>

Trade This Market

Trade on Kalshi

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

AI Analysis

About This Event

Custom AI Analysis Prompt

Educational Context

Events (1)

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Markets (5)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

Related News & Context

Discussion

Market Insights

Share

Embed Widget

Trade This Market

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

Custom AI Analysis Prompt

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

Related News & Context

Discussion

Share

Embed Widget